JPH07507326A - 陸生哺乳類の皮膚炎治療剤 - Google Patents
陸生哺乳類の皮膚炎治療剤Info
- Publication number
- JPH07507326A JPH07507326A JP6502453A JP50245394A JPH07507326A JP H07507326 A JPH07507326 A JP H07507326A JP 6502453 A JP6502453 A JP 6502453A JP 50245394 A JP50245394 A JP 50245394A JP H07507326 A JPH07507326 A JP H07507326A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- lipid
- molar ratio
- carbon atoms
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (20)
- 1.撹乱された表皮のバリアー機能によって特徴づけられる状態におかれている 陸生哺乳類の皮膚炎を処置するための方法において、前記方法が前記皮膚炎に対 して: (a)コレステロールおよび (b)アシルセラミド の脂質を含む治療的に有効量の薬剤組成物を外的に施用することを含み、脂質( a)の脂質(b)に対するモル比を約0.25:1ないし約5:1とすることを 特徴とする方法。
- 2.前記モル比が約1.5:1ないし約3.5:1であり、前記アシルセラミド のアシル基が18ないし20の炭素原子を含む脂肪酸のアシル基である請求項1 記載の方法。
- 3.前記モル比が約2:1であり、前記アシルセラミドのアシル基が18ないし 20の炭素原子を含む脂肪酸のアシル基である請求項1記載の方法。
- 4.撹乱された表皮バリア機能によって特徴づけられる状態におかれている陸生 哺乳類の皮膚炎を処置するための方法において、前記方法が前記皮膚炎に対して :(a)コレステロール、 (b)アシルセラミド、 (c)12ないし20の炭素原子を鎖中に有する少なくとも一つの脂肪酸の脂質 を含む治療的に有効量の薬剤組成物を外的に施用することを含み、脂質(a): (b):(c)のモル比を(0.25−5):(1−3):(1.5−3.5) である前記方法。
- 5.前記アシルセラミドのアシル基が18ないし20の炭素原子を含む脂肪酸の アシル基でありそして脂質(c)は16ないし18の炭素原子を含む脂肪酸であ る請求項4記載の方法。
- 6.前記アシルセラミドのアシル基が18ないし20の炭素原子を含む脂肪酸の アシル基であり;脂質(c)がパルミチン酸でありそして脂質のモル比(a): (b):(c)が(1.5−2):1:3である請求項4記載の方法。
- 7.前記アシルセラミドのアシル基が18ないし20の炭素原子を含む脂肪酸の アシル基であり;脂質(c)がパルミチン酸でありそして脂質のモル比(a): (b):(c)が4:1:2.5である請求項4記載の方法。
- 8.前記アシルセラミドのアシル基が18ないし20の炭素原子を含む脂肪酸の アシル基であり;脂質(c)がステアリン酸でありそして脂質のモル比(a): (b):(c)が2:1:3である請求項4記載の方法。
- 9.撹乱された表皮バリア機能によって特徴づけられる状態におかれている陸生 哺乳類の皮膚炎を処置するための方法において、前記方法が前記皮膚炎に対して :(a)コレステロール、 (b)セラミド、 (c)必須脂肪酸および (d)12ないし20の炭素原子を鎖中に有する非必須脂肪酸ほ脂質からなる治 療的に有効量の薬剤組成物を外的に施すことを含み、脂質(a):(b):(c ):(d)のモル比を(2−5):(1−3):(1−3):(1.5−3.5 )とすることを特徴とする方法。
- 10.前記必須脂肪酸がりノール酸でありそして前記非必須脂肪酸がパルミチン 酸およびステアリン酸からなる群より選ばれた成分である請求項9記載の方法。
- 11.前記必須脂肪酸がリノレイン酸であり、そして前記非必須脂肪酸がパルミ チン酸およびステアリン酸からなる群より選ばれた構成成分であり、そして脂質 (a):(b):(c):(d)のモル比が3:1:1:1、2:1:1:1、 2:2:1:1、1:1:1:2および1:1:1:3からなる群より選ばれる 請求項9記載の方法。
- 12.前記必須脂肪酸がりノール酸であり前記非必須脂肪酸がステアリン酸であ り、そして脂質(a):(b):(c):(d)のモル比が3:1:1:1であ る請求項9記載の方法。
- 13.撹乱された表皮バリア機能によって特徴づけられる状態におかれている陸 生哺乳類の皮膚炎を処置するための方法において、前記方法が前記皮膚炎に対し て: (a)コレステロール、および (b)グリコセラミド の脂質を含む治療的に有効量の薬剤組成物を外的に施用し、脂質(a)の脂質( b)に対するモル比を約0.25:1から約5:1とすることを特徴とする方法 。
- 14.脂質(b)がグリコシルセラミドおよびガラクトセラミドからなる群より 選ばれている構成員である請求項13記載の方法。
- 15.撹乱された表皮バリア機能によって特徴づけられる状態におかれている陸 生哺乳類の皮膚炎を処置する方法において、前記方法が前記皮膚炎に対して:( a)コレステロール、 (b)グリコセラミド、 (c)12〜20の炭素原子を鎖中に有する少なくとも一つの脂肪酸の脂質を含 む、治療的に有効量の薬剤組成物を外的に施用することを含み、(a):(b) :(c)のモル比を(0.25−5):(1−3):(1.5−3.5)とする ことを特徴とする方法。
- 16.脂質(b)がグリコシルセラミドおよびガラクトセラミドからなる群より 選ばれている構成員である請求項15記載の方法。
- 17.撹乱された表皮バリア機能によって特徴づけられる状態におかれている陸 生哺乳類の皮膚炎を処置する方法において、前記方法が前記皮膚炎に対して、グ リコセラミドとアシルグリコセラミドからなる群より選ばれ、グリコ部分がトレ ハロースである治療的に有効量の構成成分を外的に施用することを特徴とする方 法。
- 18.前記薬剤組成物がさらにペトロラクタン、グリセリンおよびワセリンとグ リセリンとの混合物からなる群より選ばれた成分を含む請求項1、4、9、13 、15または17項記載の方法。
- 19.前記脂質類が全体として約0.1ないし約60重量%の前記薬剤組成物を 含む残部が薬理学的に許容し得る担体である請求項1、4、9、13、15また は17項に記載の方法。
- 20.前記脂質類が全体として約1ないし約20重量%の前記薬剤組成物を含み 残部が薬理学的に許容し得る担体である請求項1、4、9、13、15または1 7項に記載の方法。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90105292A | 1992-06-19 | 1992-06-19 | |
US95293492A | 1992-09-29 | 1992-09-29 | |
US95360392A | 1992-09-29 | 1992-09-29 | |
US901,052 | 1992-09-29 | ||
US952,934 | 1992-09-29 | ||
US953,603 | 1992-09-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07507326A true JPH07507326A (ja) | 1995-08-10 |
JP2686365B2 JP2686365B2 (ja) | 1997-12-08 |
Family
ID=27420588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6502453A Expired - Lifetime JP2686365B2 (ja) | 1992-06-19 | 1993-06-18 | 陸生哺乳類の皮膚炎治療剤 |
Country Status (12)
Country | Link |
---|---|
US (1) | US5643899A (ja) |
EP (1) | EP0644764B1 (ja) |
JP (1) | JP2686365B2 (ja) |
KR (1) | KR0179393B1 (ja) |
AT (1) | ATE192928T1 (ja) |
AU (3) | AU670613B2 (ja) |
BR (1) | BR9306564A (ja) |
CA (1) | CA2137001C (ja) |
DE (1) | DE69328682T2 (ja) |
ES (1) | ES2145052T3 (ja) |
NZ (1) | NZ254392A (ja) |
WO (1) | WO1994000127A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005522463A (ja) * | 2002-03-13 | 2005-07-28 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | 水ベースの送達システム |
US7087646B2 (en) | 2001-03-06 | 2006-08-08 | Kao Corporation | Composition for external application |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9402453D0 (sv) * | 1994-07-12 | 1994-07-12 | Astra Ab | New pharmaceutical preparation |
GB9421185D0 (en) * | 1994-10-20 | 1994-12-07 | Unilever Plc | Personal car composition |
FR2728164B1 (fr) † | 1994-12-14 | 1997-03-21 | Oreal | Composition cosmetique ou dermatologique contenant un melange de ceramides, son utilisation pour hydrater la peau |
FR2730410B1 (fr) * | 1995-02-15 | 1997-03-21 | Oreal | Composition cosmetique comprenant une association de ceramides et son utilisation |
BR9606596A (pt) * | 1995-09-01 | 1997-10-28 | Gist Brocades Nv | Composto processo para preparar um composto composição cosmética ou farmacéutica e uso de um composto |
DE19533330A1 (de) * | 1995-09-11 | 1997-03-13 | Beiersdorf Ag | Gegen Hautkrebs wirksame topische Zubereitungen |
DE19537027A1 (de) | 1995-10-05 | 1997-04-10 | Beiersdorf Ag | Hautpflegemittel für alte Haut |
GB9602111D0 (en) * | 1996-02-02 | 1996-04-03 | Unilever Plc | Personal care composition |
DE19643587A1 (de) * | 1996-10-22 | 1998-04-23 | Beiersdorf Ag | Antiadhäsive Sterole und Sterolderivate |
USRE37770E1 (en) | 1997-01-24 | 2002-06-25 | The Regents Of The University Of California | Treatment of skin conditions by use of PPARα activators |
JP2000513745A (ja) * | 1997-05-02 | 2000-10-17 | ギスト ブロカデス ベスローテン フェンノートシャップ | 局所用抗菌組成物 |
US6136301A (en) * | 1997-05-30 | 2000-10-24 | E-L Management Corp. | Lipid mix for lip product |
FR2767056A1 (fr) * | 1997-08-07 | 1999-02-12 | Oreal | Utilisation d'un 2-amino-alcane polyol en tant qu'agent destine a traiter les signes du vieillissement cutane |
ES2207023T3 (es) | 1997-12-05 | 2004-05-16 | Cosmoferm B.V. | Composiciones que comprenden una combinacion de una base esfingoide libre y una ceramida y utilizacion de las mismas. |
FR2780886B1 (fr) * | 1998-07-08 | 2001-06-29 | Jean Noel Thorel | Composition auto-hydratante pour la peau |
US6149924A (en) * | 1998-07-20 | 2000-11-21 | Biomed Research & Technologies, Inc. | Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
CO5150202A1 (es) | 1998-12-31 | 2002-04-29 | Kimberly Clark Co | Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal |
US6287581B1 (en) * | 1999-04-23 | 2001-09-11 | Kimberly-Clark Worldwide, Inc. | Absorbent articles providing skin health benefits |
US6515029B1 (en) | 1999-04-23 | 2003-02-04 | Kimberly-Clark Worldwide, Inc. | Absorbent article having a hydrophilic lotionized bodyside liner |
US6440437B1 (en) | 2000-01-24 | 2002-08-27 | Kimberly-Clark Worldwide, Inc. | Wet wipes having skin health benefits |
US6475197B1 (en) | 1999-08-24 | 2002-11-05 | Kimberly-Clark Worldwide, Inc. | Absorbent articles having skin health benefits |
US20030077962A1 (en) * | 1999-08-24 | 2003-04-24 | Krzysik Duane Gerard | Absorbent tissues providing skin barrier enhancement |
US6534074B2 (en) * | 1999-08-24 | 2003-03-18 | Kimberly-Clark Worldwide, Inc. | Absorbent articles providing skin health benefits |
FR2799650B1 (fr) * | 1999-10-14 | 2001-12-07 | Oreal | Procede pour limiter la penetration dans la peau et/ou les fibres keratiniques d'un agent cosmetique et/ou pharmaceutique actif |
US6824785B1 (en) | 2000-02-09 | 2004-11-30 | C. Neil Kitson | Skin treatment composition and methods of use |
ES2225123T3 (es) | 2000-04-04 | 2005-03-16 | Color Access, Inc. | Composicion para mejorar la funcion de la barrera lipidica de la piel. |
US6365138B1 (en) * | 2000-04-07 | 2002-04-02 | The Regents Of The University Of California | Compositions for metabolic protection and repair of lips |
KR100370455B1 (ko) * | 2000-05-19 | 2003-01-29 | 황상민 | 아토피 피부염의 피부건조증과 손상된 피부장벽의회복력을 개선시키는 조성물 및 이를 포함하는 화장료 |
KR100374047B1 (ko) * | 2000-08-04 | 2003-03-03 | 네비온 주식회사 | 아토피 피부염의 피부건조증 회복력을 개선시키는 조성물및 이를 포함하는 화장료 |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20030139384A1 (en) * | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
US6756520B1 (en) | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
US6503526B1 (en) * | 2000-10-20 | 2003-01-07 | Kimberly-Clark Worldwide, Inc. | Absorbent articles enhancing skin barrier function |
WO2002045740A1 (en) * | 2000-12-08 | 2002-06-13 | Children's Memorial Hospital | Compositions containing gangliosides for use in the treatment of skin disorders |
JP2002179549A (ja) * | 2000-12-12 | 2002-06-26 | Kishohin Kagaku Kaiho Kenkyusho:Kk | 皮膚外用剤 |
US20020120241A1 (en) * | 2000-12-22 | 2002-08-29 | Tyrrell David John | Absorbent articles with hydrophilic compositions containing anionic polymers |
US20020120242A1 (en) * | 2000-12-22 | 2002-08-29 | Tyrrell David John | Absorbent articles with hydrophilic compositions containing botanicals |
US6749860B2 (en) | 2000-12-22 | 2004-06-15 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with non-aqueous compositions containing botanicals |
US20020128615A1 (en) | 2000-12-22 | 2002-09-12 | Tyrrell David John | Absorbent articles with non-aqueous compositions containing anionic polymers |
US7771735B2 (en) * | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
SE0102087D0 (sv) | 2001-06-13 | 2001-06-13 | Knut Haadem Med Haadem Invest | Skin preparation |
US20040043463A1 (en) * | 2002-09-03 | 2004-03-04 | Pingfan Rao | Peptide-tagged proteins and compositions for regulating features of the skin or hair; methods of making, and methods of using thereof |
US20070154437A1 (en) * | 2002-09-03 | 2007-07-05 | Pingfan Rao | Peptide-tagged proteins and methods of making and using thereof |
WO2004089357A2 (en) * | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Anti-fungal formulation of triterpene and essential oil |
US20040219177A1 (en) * | 2003-04-29 | 2004-11-04 | Jacobs Randy J. | Depleted skin barrier replenishing skin creams composition and method of application |
US20050101927A1 (en) * | 2003-09-11 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Absorbent products comprising a moisturizing and lubricating composition |
US20050058693A1 (en) * | 2003-09-11 | 2005-03-17 | Kimberly-Clark Worldwide, Inc. | Tissue products comprising a moisturizing and lubricating composition |
US20050058674A1 (en) * | 2003-09-11 | 2005-03-17 | Kimberly-Clark Worldwide, Inc. | Moisturizing and lubricating compositions |
US20050209141A1 (en) * | 2003-10-17 | 2005-09-22 | Silver Randi B | Mast cell-derived renin |
US7105263B2 (en) * | 2003-12-30 | 2006-09-12 | Samsung Electronics Company | Dry toner comprising encapsulated pigment, methods and uses |
US20060008432A1 (en) * | 2004-07-07 | 2006-01-12 | Sebastiano Scarampi | Gilsonite derived pharmaceutical delivery compositions and methods: nail applications |
WO2006053912A1 (en) | 2004-11-22 | 2006-05-26 | Symrise Gmbh & Co. Kg | Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage |
NZ563560A (en) * | 2005-06-01 | 2009-11-27 | Stiefel Res Australia Pty Ltd | Vitamin formulation for treating a dermatological skin disorder |
US20070027153A1 (en) * | 2005-07-27 | 2007-02-01 | Reeth Kevin M | Topical skin-protectant and anti-pruritic compositions |
DK1937276T3 (da) | 2005-10-12 | 2013-02-11 | Besins Healthcare Luxembourg | Forbedret testosterongel og fremgangsmåde til anvendelse deraf |
WO2007098591A2 (en) * | 2006-03-02 | 2007-09-07 | Nuvo Research Inc. | Topical nail formulation |
CA2665552C (en) * | 2006-10-13 | 2013-02-19 | Evonik Goldschmidt Gmbh | Skin treatment composition |
US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
KR101018818B1 (ko) | 2008-07-11 | 2011-03-04 | (주)아모레퍼시픽 | 유사지질 복합체 및 이를 함유하는 피부 외용제 조성물 |
US8231603B2 (en) * | 2009-02-10 | 2012-07-31 | Angiodynamics, Inc. | Irreversible electroporation and tissue regeneration |
US9138390B2 (en) | 2009-04-15 | 2015-09-22 | Conopco, Inc. | Petrolatum based composition comprising greater than 10% silicone for improved feel while remaining stable |
US8372820B2 (en) * | 2009-04-15 | 2013-02-12 | Conopco, Inc. | Composition comprising silicone oil or oils structured with compolymers carrying greater than 70% long chain alkyl group |
US9421262B2 (en) * | 2009-10-28 | 2016-08-23 | Biomed Research & Technologies, Inc. | Compositions and methods for treating dermatological conditions |
US20140031310A1 (en) * | 2011-01-18 | 2014-01-30 | John Maki | Pharmaceutical compositions and methods for making and using them |
US20150024074A1 (en) * | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies Inc. | Methods for treating skin barrier and reducing acne |
EP2829303A1 (en) * | 2013-07-22 | 2015-01-28 | Johnson & Johnson Consumer Companies Inc. | Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta |
US20160184245A1 (en) | 2013-07-25 | 2016-06-30 | Cheryl Lee Eberting | Formulations for epidermal repair |
WO2015151040A1 (en) * | 2014-04-04 | 2015-10-08 | Unifarco S.P.A. | Association of active ingredients for topical use in restructuring altered cutaneous barrier following to cutaneous diseases |
EP3177281B1 (en) * | 2014-08-08 | 2023-12-06 | Ali Research S.R.L. | Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies |
CN107405305B (zh) | 2015-01-20 | 2020-12-25 | 泰特拉德姆集团有限责任公司 | 提供粘膜和皮肤屏障恢复的通用局部药物递送载体和多因子组织保湿剂 |
US10137073B2 (en) * | 2016-01-02 | 2018-11-27 | L'oreal | Cosmetic compositions comprising ceramides and cholesterol |
GB2562270B (en) | 2017-05-10 | 2020-07-01 | Hyphens Pharma Pte Ltd | Skin barrier composition |
WO2021008678A1 (de) | 2019-07-12 | 2021-01-21 | Symrise Ag | Verwendung von n-acylhydroxyaminosäureester zur induktion der expression von superoxid-dismutase und/oder hämoxygenase |
WO2022053140A1 (en) | 2020-09-10 | 2022-03-17 | Symrise Ag | Surfactant containing formulation of pseudo-ceramides |
WO2022231448A1 (en) * | 2021-04-30 | 2022-11-03 | Carbocode S.A. | Topical compositions comprising (glyco)sphingolipids and/or (glyco)ceramides |
WO2023209655A1 (en) * | 2022-04-29 | 2023-11-02 | Carbocode S.A. | Skin cell energy booster composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
CH658785A5 (de) * | 1984-06-15 | 1986-12-15 | Pentapharm Ag | Haemostyptisch wirksames hautpflegemittel. |
JPH0657651B2 (ja) * | 1985-05-15 | 1994-08-03 | サンスタ−株式会社 | 化粧料組成物 |
JP2540296B2 (ja) * | 1985-07-31 | 1996-10-02 | 花王株式会社 | 化粧料 |
JPH0648324B2 (ja) * | 1986-02-20 | 1994-06-22 | 未来工業株式会社 | 信号線接続具の製造方法 |
JPS63192703A (ja) * | 1987-02-04 | 1988-08-10 | Kao Corp | 皮膚外用剤 |
DE3871974T2 (de) * | 1987-02-12 | 1993-01-14 | Estee Lauder Inc | Haarschutzmittel und verfahren. |
WO1990001323A1 (en) * | 1988-08-12 | 1990-02-22 | Bernstein Joel E | Method and composition for treating and preventing dry skin disorders |
FR2674748B1 (fr) * | 1991-04-03 | 1995-01-13 | Oreal | Utilisation de sphingolipides dans la preparation d'une composition cosmetique ou dermopharmaceutique protegeant la peau et les cheveux contre les effets nocifs de la pollution atmospherique. |
CA2087691A1 (en) * | 1992-01-23 | 1993-07-24 | Peter Critchley | Cosmetic compositon |
-
1993
- 1993-06-18 BR BR9306564A patent/BR9306564A/pt not_active Application Discontinuation
- 1993-06-18 AU AU46387/93A patent/AU670613B2/en not_active Expired
- 1993-06-18 DE DE69328682T patent/DE69328682T2/de not_active Expired - Lifetime
- 1993-06-18 CA CA002137001A patent/CA2137001C/en not_active Expired - Lifetime
- 1993-06-18 KR KR1019940704646A patent/KR0179393B1/ko not_active IP Right Cessation
- 1993-06-18 US US08/347,363 patent/US5643899A/en not_active Expired - Lifetime
- 1993-06-18 ES ES93916589T patent/ES2145052T3/es not_active Expired - Lifetime
- 1993-06-18 AT AT93916589T patent/ATE192928T1/de not_active IP Right Cessation
- 1993-06-18 JP JP6502453A patent/JP2686365B2/ja not_active Expired - Lifetime
- 1993-06-18 NZ NZ254392A patent/NZ254392A/en not_active IP Right Cessation
- 1993-06-18 EP EP93916589A patent/EP0644764B1/en not_active Expired - Lifetime
- 1993-06-18 WO PCT/US1993/005798 patent/WO1994000127A1/en active IP Right Grant
-
1996
- 1996-07-19 AU AU60622/96A patent/AU680169B2/en not_active Expired
- 1996-07-19 AU AU60623/96A patent/AU679413B2/en not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7087646B2 (en) | 2001-03-06 | 2006-08-08 | Kao Corporation | Composition for external application |
US7528171B2 (en) | 2001-03-06 | 2009-05-05 | Kao Corporation | Composition for external application |
US7550135B2 (en) | 2001-03-06 | 2009-06-23 | Kao Corporation | Composition for external application |
JP2005522463A (ja) * | 2002-03-13 | 2005-07-28 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | 水ベースの送達システム |
JP4806519B2 (ja) * | 2002-03-13 | 2011-11-02 | トマス スコルド | 水ベースの送達システム |
Also Published As
Publication number | Publication date |
---|---|
CA2137001C (en) | 1999-05-04 |
US5643899A (en) | 1997-07-01 |
AU680169B2 (en) | 1997-07-17 |
NZ254392A (en) | 1997-07-27 |
AU6062396A (en) | 1996-09-12 |
DE69328682D1 (de) | 2000-06-21 |
WO1994000127A1 (en) | 1994-01-06 |
AU670613B2 (en) | 1996-07-25 |
EP0644764B1 (en) | 2000-05-17 |
ES2145052T3 (es) | 2000-07-01 |
CA2137001A1 (en) | 1994-01-06 |
AU6062296A (en) | 1996-09-12 |
JP2686365B2 (ja) | 1997-12-08 |
AU4638793A (en) | 1994-01-24 |
ATE192928T1 (de) | 2000-06-15 |
EP0644764A1 (en) | 1995-03-29 |
KR0179393B1 (ko) | 1999-03-20 |
BR9306564A (pt) | 1999-01-12 |
DE69328682T2 (de) | 2000-12-28 |
AU679413B2 (en) | 1997-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07507326A (ja) | 陸生哺乳類の皮膚炎治療剤 | |
CN112315882B (zh) | 一种舒缓修护保湿面霜及其制备方法 | |
US20220031640A1 (en) | Formulations for epidural repair | |
US4610978A (en) | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same | |
US20060029657A1 (en) | Topical skin protectant compositions | |
US6964952B2 (en) | Therapeutic composition for broad spectrum dermal disease | |
JP2001510487A (ja) | 遊離スフィンゴイド塩基及びセラミドの組合せを含む組成物並びにその使用 | |
USRE33107E (en) | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same | |
US6399082B1 (en) | Mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases | |
US6406708B1 (en) | Therapeutic compositions | |
US8313756B1 (en) | Urea compositions and their methods of manufacture | |
US20020176876A1 (en) | Topical therapeutic skin care system | |
JPH11505238A (ja) | 皮膚症状処置用組成物 | |
US5561166A (en) | Urea/lactate topical compositions for dry skin | |
Lodén | 19 Clinical Evidence for the Use of Urea | |
MXPA00005078A (en) | Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080815 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080815 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090815 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090815 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100815 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110815 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120815 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120815 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130815 Year of fee payment: 16 |
|
EXPY | Cancellation because of completion of term |